30
ANTIFUNGAL DRUGS dr. Agung Wiwiek Indrayani, M.Kes Pharmacology Department Faculty of Medicine

ANTIFUNGAL FKG.ppt

Embed Size (px)

Citation preview

Page 1: ANTIFUNGAL FKG.ppt

ANTIFUNGAL DRUGS

dr. Agung Wiwiek Indrayani, M.Kes

Pharmacology Department Faculty of Medicine

dr. Agung Wiwiek Indrayani, M.Kes

Pharmacology Department Faculty of Medicine

Page 2: ANTIFUNGAL FKG.ppt

Problems

Page 3: ANTIFUNGAL FKG.ppt
Page 4: ANTIFUNGAL FKG.ppt
Page 5: ANTIFUNGAL FKG.ppt
Page 6: ANTIFUNGAL FKG.ppt
Page 7: ANTIFUNGAL FKG.ppt
Page 8: ANTIFUNGAL FKG.ppt

+ a polyene

ergosterol

ergosterol withpore

Page 9: ANTIFUNGAL FKG.ppt
Page 10: ANTIFUNGAL FKG.ppt
Page 11: ANTIFUNGAL FKG.ppt
Page 12: ANTIFUNGAL FKG.ppt
Page 13: ANTIFUNGAL FKG.ppt
Page 14: ANTIFUNGAL FKG.ppt
Page 15: ANTIFUNGAL FKG.ppt
Page 16: ANTIFUNGAL FKG.ppt

Reduction of ergosterol synthesis by inhibition of fungal cytochrome P450

enzymes

Reduction of ergosterol synthesis by inhibition of fungal cytochrome P450

enzymes

Clinical UseMany candida species, Crytococcus neoformans , the endemic mycoses (blastomycosis, coccidiodomycosis, histoplasmosis, the dermatophytes,

aspergillus infections

Clinical UseMany candida species, Crytococcus neoformans , the endemic mycoses (blastomycosis, coccidiodomycosis, histoplasmosis, the dermatophytes,

aspergillus infections

Page 17: ANTIFUNGAL FKG.ppt

Acetyl CoA

Squalene

Lanosterol

(ergosterol)

Allylaminedrugs

Azoles

Squalene-2,3 oxide

Squalene monooxygenase

14--demethylase

Page 18: ANTIFUNGAL FKG.ppt
Page 19: ANTIFUNGAL FKG.ppt

VORICONAZOLENewest triazole

Intravenous and oral formulations

Dosage 400 mg/d

Intravenous and oral formulations

Dosage 400 mg/d

Well absorbed, bioavaibility 90 %,

inhibition of P450 low

Visual disturbances 30 % patient

Less toxic > Amphotericin B

Candida species, invasive aspergillosis

Page 20: ANTIFUNGAL FKG.ppt

Echinocandins the newest antifungal agent

Only intravenous form, a single loading dose 70 mg, dailly dose 50 mg

Water soluble, highly protein bound T1/2 9-11 hours Excretion kidneys and GIT Dosage adjustment hepatic

insufficiency Disruption cell wall inhibiting synthesis

of B (1-3) glucan Invasive aspergillosis, candida

Page 21: ANTIFUNGAL FKG.ppt
Page 22: ANTIFUNGAL FKG.ppt

Very insoluble ,fungistatic, from penicillium

Oral form absorption with fatty food, 1 g/d

It binds to keratin, protecting from new infection

2-6 weeks for skin and hair infectionNail infection for monthsSerum sickness, hepatitis, drug

interaction ( warfarin and phenobarbital ),

replaced by azoles and terbinafine

Page 23: ANTIFUNGAL FKG.ppt

A synthetic allylamine , fungicidal, oral formulation, 250 mg/d

Dermatophytoses, onychomycosis Keratophilic, inhibit ergosterol

biosynthesis Accumulation of the sterol squalene

toxic organism One tablet daily 12 weeks cure rate 90

%

Page 24: ANTIFUNGAL FKG.ppt

Acetyl CoA

Squalene

Lanosterol

(ergosterol)

Allylaminedrugs

Azoles

Squalene-2,3 oxide

Squalene monooxygenase

14--demethylase

Page 25: ANTIFUNGAL FKG.ppt
Page 26: ANTIFUNGAL FKG.ppt
Page 27: ANTIFUNGAL FKG.ppt
Page 28: ANTIFUNGAL FKG.ppt
Page 29: ANTIFUNGAL FKG.ppt

RATIONALE FUNGAL DRUGS

Page 30: ANTIFUNGAL FKG.ppt

THANK YOUTHANK YOU